Thinly traded micro cap Cellular Biomedicine (NASDAQ:CBMG +84%) has regained all of Friday's ~46% drop and then some. Shares are up on more than a 6x surge in volume on the heels of its announcement ...
Administrators behind the revamping of Molecular and Cellular Biology did not have to wait long to gauge the popularity of their new programs, courses, and requirement changes, said Alexander F.
Cellular Biomedicine (NASDAQ:CBMG) acquires the exclusive rights to CD40LGVAX, a cancer therapeutic vaccine that has shown potential efficacy for the treatment on non-small cell lung cancer (NSCLC), ...
Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular ...
CAMBRIDGE, Mass. & SAN DIEGO--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) today announced a strategic collaboration to advance initial programs in Be ...
Lensless microscopes have simple and compact optics that, together with associated computational algorithms, allow for large fields of view and the refocusing of the captured images. One limitation of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma (“Be Bio”), a pioneer in the discovery and development of Engineered B Cell Medicines (BeCM), today announced the closing of a $130 million financing, ...
Cellular senescence is a multifaceted process that arrests the proliferation of cells that are at risk of neoplastic transformation. Many stimuli elicit a senescence response. These include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback